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Objective: To examine the effect of acceleration and decel-
eration distance (0, 1, 2 and 3 m) on the comfortable and 
maximum walking speeds in: (i) the 5-m walk test (5mWT); 
and (ii) the 10-m walk test (10mWT) in people with chronic 
stroke.
Design: Cross-sectional study.
Setting: University-based rehabilitation centre.
Subjects: Thirty individuals with chronic stroke.
Methods: Timed walking at comfortable and maximum 
walking speeds in the 5mWT and 10mWT with different ac-
celeration and deceleration distances (0, 1, 2 and 3 m).
Results: The comfortable walking speed in the 5mWT with 
0 m acceleration and deceleration distance was significantly 
slower than that with 1, 2 or 3 m acceleration and decelera-
tion distances (p < 0.0083), but there was no significant dif-
ference among 1, 2 and 3 m acceleration and deceleration 
distances. No significant difference was found in the maxi-
mum walking speed in the 5mWT, or in the comfortable and 
maximum walking speeds of the 10mWT.
Conclusion: Adoption of 1 m acceleration and deceleration 
distance is recommended when measuring the comfortable 
walking speed in the 5mWT in people with stroke. Neither 
acceleration nor deceleration distance is needed when meas-
uring the maximum walking speed in the 5mWT, the com-
fortable walking speed or the maximum walking speed in 
the 10mWT.
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INTRODUCTION
Stroke is a common and worldwide cause of long-term dis-
ability, and walking was commonly impaired in people with 
stroke (1, 2). Although some people with stroke can walk 
independently, many walk with compensating strategies that 
significantly reduce their walking speed and endurance (3, 4). 
Among different walking tests, walking speed has been shown 
to be the strongest independent predictor of self-reported motor 
function in people with stroke (5). 
The 10-m walk test (10mWT) was developed 20 years ago to 
measure walking speed (6). It is now widely used to measure the 
walking speed of healthy adults (5, 7) as well as patients with 
neurological disorders (8), including people with stroke (1, 4, 
8–15). It involves walking for 10 m at comfortable and maxi-
mum speeds, which is timed and walking speed is calculated. 
In recent decades, the 5-m walk test (5mWT) has also evolved 
in response to the reduced walking endurance of patients and 
limited clinical space (4, 14, 15, 16). Both the 5mWT and the 
10mWT have shown good reliability in assessing the walking 
speed in people with stroke (intraclass correlation coefficient 
(ICC) of the 5mWT = 0.86; and the 10mWT at a comfortable 
speed = 0.90–0.97; 10mWT at maximum speed = 0.95–0.98) (2, 
15). The good validity of these measures is reflected by their 
excellent correlation with functional activities, including balance 
and mobility (9). In addition, the 10mWT is sensitive to a clini-
cal improvement (standard error of measurement at comfortable 
speed = 7.9%; maximum speed = 5.7%) (2). 
Reaching a steady walking speed in the 5mWT and 10mWT 
involves acceleration and deceleration distance (17). The total 
walkway length has a significant influence on walking speed 
(16). However, the acceleration and deceleration distance 
adopted in previous studies using the 5mWT and 10mWT was 
not standardized. Various studies have adopted acceleration and 
deceleration distances of 0 m (1, 5, 11), 0.5 m (13), 1.5 m (14) 
and 2 m (2, 7, 8, 10, 12, 15), or even not mentioned it (3, 9). 
To our knowledge, no published study has examined the effect 
of acceleration and deceleration distance on comfortable and 
maximum walking speeds in either the 5mWT or the 10mWT 
in people with stroke. 
The aim of this study is to examine the effect of acceleration 
and deceleration distance (0, 1, 2 and 3 m) on comfortable 
and maximum walking speeds in (i) 5mWT and (ii) 10mWT 
in people with chronic stroke.
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METHODS
Participants
This was a cross-sectional study. Participants were included if they: 
(i) had been diagnosed with stroke for more than 1 year, (ii) were at 
least 50 years old, (iii) were able to walk at least 16 m with or without 
walking aids, but without any manual assistance, (iv) could follow 
instructions in Cantonese or English, (v) scored at least 7 on the Ab-
breviated Mental Test (18), and had a stable general medical condition 
that would allow them to participate in the test.
Participants were excluded if they had: (i) co-morbid neurological 
disorders other than stroke, for example, Parkinson’s disease, (ii) 
unstable medical or orthopaedic conditions that might affect their 
walking performance.
Calculated via G* Power 3.1.9.2, a sample size of ≥ 29 is required 
to achieve a statistically significant difference for an effect size of 
difference f = 0.1, setting the level of statistical significance at α = 0.05 
and the power at 80% (β = 0.2). Thirty participants (21 men, 9 women 
with mean age and standard deviation (SD) 61.23 (SD 6.65)) with a 
mean post-stroke duration of 10.09 (SD 4.66) years were recruited 
from a local self-help group in Hong Kong (Table I). 
The study was approved by the ethics committee of the local institu-
tion and conducted according to the Declaration of Helsinki for human 
experiments. Clear explanation was given and written consent was 
obtained from all of the participants before the assessment. 
Outcome measures
Comfortable and maximum walking speeds in the 5mWT and 10mWT 
were measured. They were conducted in a corridor over a walkway 
marked with coloured lines at 2 ends according to conditions with 
different acceleration and deceleration distances (0, 1, 2 and 3 m). 
There were 16 conditions in total; 8 for comfortable walking speed 
and 8 for maximum walking speed (Table II). The participants were 
timed walking along the 5 m and 10 m walkway length using a digital 
stopwatch. The standardized instructions “walk at your most comfort-
able speed” and “walk as quickly and safely as you can” were given 
for comfortable walking and maximum walking speeds, respectively.
Each participant completed 16 conditions, for which the sequence 
was randomized by drawing lots. They were required to complete 3 
trials for each condition. At least 30 s of rest was given between trials 
to avoid fatigue. Mean speed (m/s) was calculated by averaging the 
speed in the 3 trials.
Statistical analysis
Table I shows the descriptive statistics of the demographic character-
istics of our participants. The effect of acceleration and deceleration 
distance on walking speed was analysed by one-way repeated meas-
ures analysis of variance (ANOVA). The acceleration and decelera-
tion distances were the only factors with 4 levels (0, 1, 2 and 3 m). 
Walking speed was measured repeatedly and the mean walking speed 
was used for statistical analysis. The analysis was conducted via the 
Statistical Package for the Social Sciences (SPSS) software. The level 
of statistical significance is set at α = 0.05. A post-hoc paired t-test with 
the Bonferroni correction was run if a statistical significance is shown 
in the one-way repeated measures ANOVA, with p-value < 0.0083 
sconsidered as statistically significant. Correlations between walking 
speed and factors including age, duration of stroke, number of stroke 
and number of falls were examined by Pearson’s r.
RESULTS
Both comfortable and maximum walking speeds of both the 
5mWT and the 10wMT were summarized in Table III.
5mWT
One-way repeated measures ANOVA showed a significant 
difference in the comfortable walking speed among the 4 
conditions with 0, 1, 2 and 3 m acceleration and deceleration 
distances (p = 0.001). A post-hoc paired t-test with the Bonfer-
roni correction was run, with p-value < 0.0083 considered as 
statistically significant. The post-hoc result indicated that the 
comfortable walking speed with 0 m acceleration and decel-
eration distance was significantly different from that with 1, 2 
and 3 m acceleration and deceleration distances (p < 0.0083), 
while there was no significant difference in the comfortable 
walking speed among 1, 2 and 3 m acceleration and decelera-
tion distances (Fig. 1). At the maximum walking speed, there 
was no significant difference among the 4 conditions.
10mWT
No significant difference in the comfortable or maximum 
walking speeds was shown among the 4 conditions with 0, 1, 
2 and 3 m acceleration and deceleration distances. 
DISCUSSION
This is the first study to systematically investigate the effect 
of acceleration and deceleration distance on walking speed in 
people with chronic stroke.
Table I. Descriptive characteristics of the participants (n = 30)
Variables n %
Sex (male/female) 21/9 70/30
Type of stroke (ischaemic/haemorrhagic) 18/12 60/40
Side of hemiplegia (left/right) 11/19 36.7/63.3
Number of stroke attacks (once/twice) 29/1 96.7/3.3
Mobility status (unaided/stick/quadripod) 19/8/3 63.3/26.7/10
Ankle-foot-orthosis (yes/no) 2/28 6.7/93.3
Number of falls within 1 year (0/1/2/3) 25/3/1/1 83.3/10.0/3.3/3.3
Mean (SD) [range]
Age (years) 61.23 (6.65) [50–73]
Body weight (kg) 66.63 (11.48) [48.3–98.3]
Height (m) 1.63 (0.07) [1.48–1.79]
BMI (kg/m2) 25.10 (3.17) [19.35–32.84]
Duration of stroke (years) 10.09 (4.66) [4.67–23.00]
BMI: body mass index; SD: standard deviation.
Table II. Conditions with different combinations of walk test (5mWT and 
10mWT) and acceleration and deceleration distances (0, 1, 2 and 3 m)
Walk test
Walking 
strategy
Acceleration and deceleration distance
0 m 1 m 2 m 3 m
5mWT Comfortable 
speed COND 1 COND 3 COND 5 COND 7
Maximum 
speed COND 2 COND 4 COND 6 COND 8
10mWT Comfortable 
speed COND 9 COND 11 COND 13 COND 15
Maximum 
speed COND 10 COND 12 COND 14 COND 16
COND: condition; 5mWT: 5-m walk test; 10mWT: 10-m walk test.
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Walking performance in people with stroke
Comfortable walking speed is intended to reflect the way 
people walk comfortably and naturally most of the time (4). 
The maximum walking speed reflects the ability of people 
to manage daily tasks requiring fast walking speed, such as 
crossing the road (5, 7). In the 5mWT, the comfortable walking 
speed of our participants was 0.73 m/s, whereas the maximum 
walking speed was 0.93 m/s. In the 10mWT, their comfortable 
walking speed was 0.78 m/s, whereas the maximum walking 
speed was 0.95 m/s. 
Compared with previous studies on the walking speed in 
people with stroke, our results in both comfortable and maxi-
mum walking speeds in the 5mWT were consistent with Ng et 
al.’s study (comfortable walking speed = 0.76 m/s, maximum 
walking speed = 0.99 m/s) (4). In our 10mWT, a consistent 
comfortable walking speed (0.79–0.94 m/s) and a comparable 
maximum walking speed (1.00–1.4 m/s) were also shown (2, 
4, 12). According to the study of Taylor-Piliae and colleagues 
(19), the comfortable walking speed of our participants in the 
10mWT was considered as limited community walker (0.4–0.8 
m/s), meaning they can be independent in at least one moder-
ate community activity, such as having meal in restaurant, but 
cannot walk in crowds or on uneven terrains (11).
The slightly slower walking speed among our participants 
compared with people with stroke in previous studies (5, 20, 
21) can probably be explained by their demographic charac-
teristics. First, the mean age of our participants is 61.23 years, 
which is higher than previous studies (2, 4, 12). Secondly, 70% 
of our participants are males and it is less than those in previous 
studies (2, 4, 12). Since males are more able to produce rapid 
lower extremity muscle torques than females, they are known 
to have faster comfortable and maximum walking speeds (20). 
Compared with the walking speed of older adults without 
stroke from past studies, our participants had a slower com-
fortable and maximum walking speeds (5, 7). Among older 
adults without stroke, the comfortable and maximum walking 
speeds were 1.22 and 1.79 m/s, respectively, in the 5mWT (7), 
while the comfortable and maximum walking speeds ranged 
from 1.07 to 1.43 m/s and 1.66 to 1.94 m/s, respectively, in 
the 10mWT (5, 7). 
As for the ability to increase to the maximum walking speed 
beyond comfortable walking speed, our participants could in-
crease their walking speed by 25.0–27.4%, which is consistent 
with that reported by Dobkin and colleagues (22). It had been 
reported that people with chronic stroke who were independent 
walkers and over 60 years of age can only increase their walk-
ing speed by approximately 25%, while older adults without 
stroke can increase their walking speed by 25–50% (22).
Stroke-specific impairments significantly affect the walking 
speed in people with stroke (5, 20, 21). Spasticity, deficits in 
sensation and perception, and muscle weakness are 
all common characteristics of stroke (21). Altered 
motor neuron pool activation and recruitment patterns, 
reduced motor unit discharge rate (23), slow modu-
lation of firing rates (24) and gross atrophy (25) all 
contribute to the deficits in muscle strength and control 
in people with stroke (23). Indeed, muscle weakness 
over the lower extremities is associated with a slower 
walking speed (10).
Effect of acceleration and deceleration distance
In this study, the only significant effect was found 
at comfortable walking speed in the 5mWT. The 
comfortable walking speed in the 5mWT with 0 m 
acceleration and deceleration distance was signifi-
cantly slower than that with 1, 2 or 3 m acceleration 
and deceleration distances. People with stroke ap-
parently require a certain distance to reach a steady, 
comfortable walking speed and to terminate their 
Table III. Comfortable and maximum walking speed measured in 5mWT and 10mWT with 0, 1, 2 and 3 m acceleration and deceleration distances
Walk test
Walking speed, m/s
paWalking strategy
0 m
Mean (SD)
1 m
Mean (SD)
2 m
Mean (SD)
3 m
Mean (SD)
Overall
Mean (SD)
5mWT Comfortable speed 0.69 (0.17) 0.73 (0.18) 0.74 (0.20) 0.74 (0.18) 0.73 (0.18) 0.001*
Maximum speed 0.91 (0.28) 0.93 (0.27 0.92 (0.26) 0.94 (0.28) 0.93 (0.27) 0.122
10mWT Comfortable speed 0.75 (0.19) 0.76 (0.20) 0.76 (0.18) 0.78 (0.20) 0.76 (0.19) 0.225
Maximum speed 0.93 (0.28) 0.96 (0.30) 0.96 (0.30) 0.96 (0.30) 0.95 (0.29) 0.052
aEffect of acceleration and deceleration distance with each walking strategy was analysed using one-way repeated analysis of variance (ANOVA).
*Statistically significant difference in mean walking speed among 4 conditions with 0, 1, 2 and 3 m acceleration and deceleration distances.
5mWT: 5-m walk test; 10mWT: 10-m walk test; SD: standard deviation.
Fig 1. Mean comfortable walking speed measured in 5mWT with 0, 1, 2 and 
3 m acceleration and deceleration distances. Pb; P value of post-hoc analysis. 
*Statistically significant difference in mean comfortable walking speed between 
two groups (p < 0.0083).
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walking. They may start the walk slowly to lower the fall risk 
by reducing the acceleration of the upper body (3). Without 
acceleration and deceleration distance, the walking speed 
measured tends to be an average one instead of a steady one. 
Macfarlane & Looney’s study (17) on older adults without 
walking impairment, found that a mean of 2.17 m acceleration 
distance and 1.80 m deceleration distance was required to reach 
a steady comfortable walking speed over a 15-m walkway. Yet, 
the acceleration and deceleration distance required may be 
shorter for people with stroke, as they may adopt a different 
walking strategy. Based on our results, therefore, 1 m accel-
eration and deceleration distance is suggested to be sufficient 
for people with stroke for reaching their steady, comfortable 
speed in the 5mWT.
No significant difference was found at comfortable walking 
speed in 10mWT with different acceleration and deceleration 
distances (0, 1, 2 and 3 m). It implies that no acceleration and 
deceleration distance is needed when assessing comfortable 
walking speed in the 10mWT. Ng et al. (4) compared comfort-
able walking speed in the 5mWT and 10mWT in people with 
stroke, both with 2 m acceleration and deceleration distance. 
The results showed that there was no significant difference in 
the walking speed. Combining with our results, it appears that 
there is only a significant change at the comfortable walking 
speed when the total walkway length is between 5 (0+5+0) m 
and 7 (1+5+1) m. One of the possible reasons is that when the 
total walkway length exceeds 7 m, the effect of acceleration 
and deceleration distance on walking speed is diminished and 
its effect becomes insignificant. 
Apart from the effect of acceleration and deceleration dis-
tance, the significant difference in the walking speed may be 
due to the change in walking strategy. It has been reported that 
older adults without stroke adopt different walking strategies 
depending on the walkway length (26). A long walkway length 
(> 20 m) elicits a higher stride velocity and a shorter gait cycle, 
compared with a shorter walkway length (< 10 m) in healthy 
older adults (26). Whether people with stroke adopt similar 
strategy as older adults is unknown. However, it should be 
noted that the definition of both “long” and “short” walkways 
would probably be shorter to people with stroke, because of 
their compromised walking endurance (27). 
It is surprising to note that no significant difference was 
found in maximum walking speed in either 5mWT or 10mWT, 
with any acceleration and deceleration distance (0, 1, 2 and 3 
m). It implies that no acceleration or deceleration distance is 
needed when measuring the maximum walking speed in 5mWT 
or 10mWT. A potential explanation is that participants were 
instructed to walk as quickly and safely as they could before 
the assessment as standardized instruction. Acceleration and 
deceleration, therefore, took place in a much more rapid man-
ner, compared with when walking at the comfortable speed. It 
has been reported that acceleration and deceleration distance 
in maximum walking is shorter than that in comfortable walk-
ing (17). The effect of acceleration and deceleration, which 
is further diminished at maximum walking speed, becomes 
insignificant.
Study limitations
Several limitations were noted in this study. This study focused 
only on walking speed and therefore, gait quality was not 
observed. Further studies could be conducted to investigate 
the effect of acceleration and deceleration distance with other 
gait parameters, such as step length, cadence and gait pattern. 
In addition, the sample size (n = 30) of this study might be too 
small to detect any significant effect in all conditions. Also, 
our participants were community dwelling people with chronic 
stroke. Thus, our results could only be generalized to people 
with stroke who fulfil similar inclusion criteria. Further stud-
ies are required to investigate the effect of acceleration and 
deceleration distance on walking speed of people with acute 
or subacute stroke who have poorer walking capacities. 
Our results could only be applied to similar environments 
either, i.e. indoor with a flat surface and no obstacles. There 
might be a different result when the study is done in an out-
door environment. The walking speed of participants might be 
affected as the investigator had to walk behind them closely 
during the test to ensure safety. There might also be learning 
and fatigue effects, since participants were required to walk 
in all 16 conditions with 3 trials each. In order to minimize 
the learning and fatigue effect, the testing sequence was ran-
domized and at least 30 s of resting was allowed. 
The study was designed to identify any effect of acceleration 
and deceleration distance on walking speed in the 5mWT and 
10mWT. Thus, the optimal acceleration and deceleration dis-
tance required was not found. Only 0, 1, 2 and 3 m acceleration 
and deceleration distances were adopted in our study. The effect 
of acceleration and deceleration distance was only significant 
at comfortable walking speed in the 5mWT between 0 m and 
1 m acceleration and deceleration distance, which means that 
the optimal acceleration and deceleration distance could be 
within this range. Further studies are needed to identify the 
optimal acceleration and deceleration distance required for 
measuring the comfortable walking speed in the 5mWT in 
people with stroke. 
We also assumed that the same acceleration and decelera-
tion distance were required. However, people with stroke may 
need different combinations of acceleration and deceleration 
distance in reaching their steady walking speed. Hence, dif-
ferent combinations of acceleration and deceleration distance 
in further study can delineate the exact distance required in 
the 5mWT. 
Conclusion
This is the first study to examine the effect of acceleration and 
deceleration distance on the comfortable and maximum walk-
ing speeds in the 5mWT and 10mWT in people with chronic 
stroke. Based on our results, in people with stroke, the 5mWT 
with maximum walking speed and 10mWT with comfortable 
or maximum walking speeds do not require any additional 
distance for acceleration and deceleration. On the other hand, 
the 5mWT with comfortable walking speed requires at least 1 
m for acceleration and deceleration. This poses a significant 
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impact on current practice, as a shorter walkway can minimize 
potential fatigue in people with stroke and it is also beneficial 
to clinical settings with limited space.
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